Related Experiment Video
Updated: Jun 27, 2025
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Integrated machine learning-based virtual screening and biological evaluation for identification of potential
Shahid Parwez1,2, Animesh Chaurasia1,2, Pinaki Parsad Mahapatra1,2
1Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India.
Abstract:
Cathepsin K is a type of cysteine proteinase that is primarily expressed in osteoclasts and has a key role in the breakdown of bone matrix protein during bone resorption. Many studies suggest that the deficiency of cathepsin K is concomitant with a suppression of osteoclast functioning, therefore rendering the resorptive properties of cathepsin K the most prominent target for osteoporosis. This innovative work has identified a novel anti-osteoporotic agent against Cathepsin K by using a comparison of machine learning and deep learning-based virtual screening followed by their biological evaluation. Out of ten shortlisted compounds, five of the compounds (JFD02945, JFD02944, RJC01981, KM08968 and SB01934) exhibit more than 50% inhibition of the Cathepsin K activity at 0.1 μM concentration and are considered to have a promising inhibitory effect against Cathepsin K. The comprehensive docking, MD simulation, and MM/PBSA investigations affirm the stable and effective interaction of these compounds with Cathepsin K to inhibit its function. Furthermore, the compounds RJC01981, KM08968 and SB01934 are represented to have promising anti-osteoporotic properties for the management of osteoporosis owing to their significantly well predicted ADMET properties.
Insights
Researchers identified novel compounds that inhibit Cathepsin K, a key target for osteoporosis treatment. Five compounds showed significant Cathepsin K inhibition, with three demonstrating promising anti-osteoporotic potential and favorable drug-like properties.
Area of Science:
- Biochemistry
- Pharmacology
- Computational Chemistry
Background:
- Cathepsin K, a cysteine proteinase in osteoclasts, is crucial for bone resorption.
- Its deficiency is linked to suppressed osteoclast function, making it a prime target for osteoporosis therapy.
Purpose of the Study:
- To identify novel anti-osteoporotic agents targeting Cathepsin K.
- To evaluate the efficacy of machine learning and deep learning-based virtual screening in drug discovery.
Main Methods:
- Comparative virtual screening using machine learning and deep learning models.
- Biological evaluation of shortlisted compounds against Cathepsin K.
- Molecular docking, molecular dynamics (MD) simulations, and MM/PBSA analyses.
- Assessment of ADMET properties for potential drug candidates.
Main Results:
- Five compounds (JFD02945, JFD02944, RJC01981, KM08968, SB01934) demonstrated over 50% Cathepsin K inhibition at 0.1 μM.
- Molecular simulations confirmed stable and effective interactions between these compounds and Cathepsin K.
- Compounds RJC01981, KM08968, and SB01934 exhibited promising anti-osteoporotic properties with favorable predicted ADMET profiles.
Conclusions:
- Novel compounds targeting Cathepsin K have been identified through integrated computational and experimental approaches.
- The identified compounds, particularly RJC01981, KM08968, and SB01934, represent promising candidates for osteoporosis management.
- This study highlights the effectiveness of combining machine learning, deep learning, and biophysical methods for accelerated drug discovery.
